Blueprint Medicines Corp (19)

Browse by Contract Category

Contracts

Amended and Restated Employment Agreement, dated January 11, 2021, by and between the Registrant and Becker Hewes, M.D (Filed With SEC on January 11, 2021)
Sales Agreement, dated as of July 30, 2020, by and between Blueprint Medicines Corporation and Cowen and Company, LLC (Filed With SEC on July 31, 2020)
2015 Employee Stock Purchase Plan (Filed With SEC on February 13, 2020)
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on February 13, 2020)
License Agreement, effective October 15, 2019, by and between Blueprint Medicines Corporation and Clementia Pharmaceuticals, Inc (Filed With SEC on November 5, 2019)
First Amendment to Employment Agreement, dated January 11, 2021, by and between Blueprint Medicines Corporation and Anthony L. Boral, M.D., Ph.D (Filed With SEC on January 11, 2021)
Employment Agreement, effective September 1, 2020, by and between Blueprint Medicines Corporation and Fouad Namouni, M.D (Filed With SEC on September 1, 2020)
Eighth Amendment to Collaboration and License Agreement, effective April 30, 2020, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation (Filed With SEC on May 6, 2020)
Employment Agreement, dated November 22, 2017, by and between the Registrant and Debra Durso-Bumpus, as amended by the First Amendment to Employment Agreement, dated February 10,... (Filed With SEC on February 13, 2020)
2015 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated as of January 22, 2020, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on January 23, 2020)
Seventh Amendment to Collaboration and License Agreement, effective December 17, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines... (Filed With SEC on December 20, 2019)
Sixth Amendment to Collaboration and License Agreement, effective November 1, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines... (Filed With SEC on November 5, 2019)
Fifth Amendment to Collaboration and License Agreement, effective June 28, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation (Filed With SEC on July 3, 2019)
Underwriting Agreement, dated as of March 28, 2019, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on March 29, 2019)
Employment Agreement, effective March 6, 2019, by and between Blueprint Medicines Corporation and Ariel Hurley (Filed With SEC on March 8, 2019)
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant (Filed With SEC on February 26, 2019)
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Michael Landsittel (Filed With SEC on February 5, 2019)
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Kathryn Haviland (Filed With SEC on February 5, 2019)